A patient has a loss-of-function mutation in phenylalanine hydroxylase (PKU). Which set of metabolic consequences would you expect?
AElevated blood tyrosine and reduced phenylalanine, because the blocked enzyme normally degrades phenylalanine
BReduced catecholamine synthesis and elevated serotonin, as the tryptophan pathway compensates
CAccumulation of phenylalanine in blood and reduced tyrosine production, because the hydroxylation step converting phenylalanine to tyrosine is blocked
DDeficiency of NAD+ because phenylalanine normally feeds into the kynurenine pathway
Phenylalanine hydroxylase converts phenylalanine to tyrosine; when this enzyme fails, phenylalanine cannot enter the tyrosine pathway and accumulates. Because phenylalanine must be converted to tyrosine before further catabolism, tyrosine must now be obtained entirely from the diet — it becomes conditionally essential. The toxic accumulation of phenylalanine and its transamination products causes neurological damage. NAD+ synthesis comes from tryptophan (kynurenine pathway), not phenylalanine.
Question 2 Multiple Choice
Which molecule is the direct biosynthetic precursor to both dopamine (a neurotransmitter) and thyroid hormones (T3/T4)?
APhenylalanine — it is converted directly to L-DOPA in catecholamine synthesis
BTryptophan — it serves as the universal aromatic amino acid precursor for signaling molecules
CTyrosine — it is hydroxylated to L-DOPA for catecholamine synthesis and iodinated for thyroid hormone synthesis
DL-DOPA — it is the central hub molecule for all catecholamine and thyroid hormone biosynthesis
Tyrosine is the true metabolic hub. For catecholamines: tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine. For thyroid hormones: tyrosine residues within thyroglobulin are iodinated and coupled to form T3 and T4. Phenylalanine must first be converted to tyrosine before it can enter any of these pathways — it is not a direct precursor. L-DOPA is an intermediate, not a hub upstream of thyroid hormones.
Question 3 True / False
Tryptophan serves as a dietary source for de novo NAD+ biosynthesis because the kynurenine pathway produces a pyridine nucleotide precursor.
TTrue
FFalse
Answer: True
True — the major catabolic route for tryptophan is the kynurenine pathway, which opens the indole ring and produces several intermediates, including quinolinate. Quinolinate is a direct precursor for NAD+ synthesis. This is why tryptophan is considered a niacin equivalent in nutrition: adequate dietary tryptophan can partially compensate for niacin (vitamin B3) deficiency, since NAD+ can be synthesized from either.
Question 4 True / False
Phenylalanine and tyrosine are catabolized through largely separate biochemical pathways with no shared intermediates or enzymatic steps.
TTrue
FFalse
Answer: False
False — phenylalanine is first converted to tyrosine by phenylalanine hydroxylase, after which both amino acids enter the same downstream degradation pathway. This convergence is why tyrosine is described as the metabolic hub: whether the aromatic carbon enters as phenylalanine or tyrosine, it passes through the same sequence leading to fumarate (glucogenic) and acetoacetate (ketogenic). The two pathways are not separate; they merge at tyrosine.
Question 5 Short Answer
Why is tyrosine described as a 'metabolic hub' among the aromatic amino acids? Name two distinct physiological systems that depend on tyrosine as their biosynthetic starting point.
Think about your answer, then reveal below.
Model answer: Tyrosine is the convergence point for phenylalanine catabolism and the upstream precursor for multiple major biosynthetic pathways. Two distinct systems: (1) the catecholamine neurotransmitter/hormone system — tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine, which governs motor control, reward, and stress response; and (2) thyroid hormone synthesis — tyrosine residues in thyroglobulin are iodinated and coupled to form T3 and T4, which regulate metabolism and thermogenesis. Melanin synthesis in skin is a third pathway.
The term 'hub' is warranted because multiple upstream pathways (phenylalanine input) and multiple downstream biosynthetic branches all pass through tyrosine. This means defects in tyrosine availability — whether from PKU or dietary restriction — have cascading effects across unrelated physiological systems.